Sort   by:  
 Page size 
ProteomicsCombining proteomics and machine learning to identify triple negative breast cancer biomarkers binding telomeric G-Quadruplex
Triple-negative breast cancer (TNBC) lacks ER, PR and HER2 expression, represents ~10–20% of invasive breast cancers, and is clinically aggressive with limited targeted treatment options. Its pronounced molecular heterogeneity challenges single-marker diagnostics, motivating the development of robus...
ORGANISM(S): Homo sapiens (Human) 
2026-05-29 | PXD072964 | Pride
Tel46 Tnbc Gquadruplex Cancer Breast Dna Quantitative proteomics Biomarkes 
ProteomicsCombining proteomics and machine learning to identify potential triple negative breast cancer biomarkers binding telomeric G-Quadruplex
Triple-negative breast cancer (TNBC) lacks ER, PR and HER2 expression, represents ~10–20% of invasive breast cancers, and is clinically aggressive with limited targeted treatment options. Its pronounced molecular heterogeneity challenges single-marker diagnostics, motivating the development of robus...
ORGANISM(S): Homo sapiens (Human) 
2026-05-29 | PXD072866 | Pride
Aptamers Pulldown Cancer Tnbc Gquadruplex Tumor Triple negative breast cancer Human G4 
UnknownTocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Not available
S-EPMC7576974 | biostudies-literature
Sort   by:  
 Page size